NO142866B - Nye benzodiazepinderivater for anvendelse som ugangsmateriale og fremgangsmaate ved fremstilling derav - Google Patents
Nye benzodiazepinderivater for anvendelse som ugangsmateriale og fremgangsmaate ved fremstilling derav Download PDFInfo
- Publication number
- NO142866B NO142866B NO1797/73A NO179773A NO142866B NO 142866 B NO142866 B NO 142866B NO 1797/73 A NO1797/73 A NO 1797/73A NO 179773 A NO179773 A NO 179773A NO 142866 B NO142866 B NO 142866B
- Authority
- NO
- Norway
- Prior art keywords
- poliomyelitis
- sugar
- procedures
- producing
- benzodiazepine derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 8
- 229940053197 benzodiazepine derivative antiepileptics Drugs 0.000 title 1
- 150000001557 benzodiazepines Chemical class 0.000 title 1
- 208000000474 Poliomyelitis Diseases 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 15
- 241000700605 Viruses Species 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000002238 attenuated effect Effects 0.000 claims description 4
- 241000991587 Enterovirus C Species 0.000 description 12
- 241000274177 Juniperus sabina Species 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- 229960001539 poliomyelitis vaccine Drugs 0.000 description 3
- 235000020374 simple syrup Nutrition 0.000 description 3
- 239000007900 aqueous suspension Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D245/06—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
Fremgangsmåte til fremstilling av holdbare poliomyelitvirus-preparater til oral administrasjon.
Oppfinnelsen vedrører en fremgangsmåte til fremstilling av holdbare, oralt administrerbare poliomyelit-virus-preparater av avsvekkede levende poliomyelitvirus.
Man har allerede forsøkt å bringe poliomyelitvirus som skal inntas oralt i en hold-bar form ved at man innelukker dem i kapsler. Denne fremgangsmåte er imidler-tid meget omstendelig og tidsrøvende. Dessuten vil kapsler helst ikke inntas av mange pasienter, spesielt småbarn. Det er også allerede foreslått å blande polio-virusen med sukker og å administrere i sukkersirup eller i form av bonboner (sml. U.S.-patent nr. 2 966 443, Academy of Medical Science of the USSR, Inst. for Poliomyelitis Rese-arch, Moskau, 1960, rapport nr. 2 (31/12 1959), side 66, 72, 73). Sukkersirup er imid-lertid bare vanskelig doserbar og dessuten er poliovirer bare holdbare noen få dager, såvel i sukkersirup som også i bonbons ved værelsestemperatur. Det er heller ikke mu-lig å overføre en for den administrasjon beregnede poliovirus-suspensjon i en hold-bar form ved frysetørkning, da dens in-fektiositet derved forstyrres, og vaksinen således ikke mere har noen virkning. Man måtte tidligere hjelpe seg med å innfryse poliomyelitvaksinen som sådan og tran-sportere den i frossen tilstand og å opptine den umiddelbart før applikasjonen.
Det er nu blitt funnet at man kan fremstille holdbare oralt administrerbare poliomyelitvirus-preparater på enkel måte ved at man påfører poliomyelitvira på sukkerkjerner, og lar de tørke under sterile betingelser.
For gjennomføring av fremgangsmåten går man hensiktsmessig frem således, at man påfører en vandig suspensjon av levende avsvekkede poliomyelitvira f. eks. av typen I (Sabin) med en ID-(I IO7835 på sukkerkjerner, og lar det tørke fortrinnsvis under sterile betingelser. For å påskynde tørkningsprosessen kan man arbeide under nedsatt trykk eller anvende en steril gass-strøm f. eks. luftstrøm. Tørkningstempera-turen ligger mellom 0 og 37° C, fortrinnsvis mellom 20 og 37° C. Titerbestemmelsen foregår på kjent måte i vevkulturen.
Ved fremgangsmåten ifølge oppfinnelsen fåes et oralt virksomt poliopodnings-stoff av god stabilitet. Holdbarheten av kjente oralt administrerbare poliopod-ningsstoffer i ikke frosset tilstand utgjør som allerede nevnt ved værelsestemperatur f. eks. bare noen dager, mens poliomyelit-virus-preparater fremstilt ifølge oppfinnelsen ved værelsestemperatur er holdbare i 6 uker uten innvirkning på virkningen. Denne egenskap er å anse som stor fordel for den brede anvendbarhet av orale polio-levende-podestoffer.
De følgende eksempler forklarer fremstillingen av podningsstoff-preparater på sukkergjerner på hvis overflate det er på-tørket levende, avsvekkede polio vira av typen I, II og III, såvel som en blanding av de tre typer. Pr. sukkerkjerne påføres den for injeksjonen av et menneske nødvendige dose, ca. 200 000—500 000 TCID5() (TCID5(1 = tissue culture ID5„).
Det kan riktignok til lagring også utstyres sukkerkjerner med en høyere dose av poliovira, f. eks. flere ganger av en for infeksjonen av et menneske nødvendig dose. Således lar det seg fremstille «Multidose»-preparater til lagring, som f. eks. inneholder 50- eller 100-ganger den ovennevnte dose. Før administrasjon må de oppløses, da de tjener til tilsvarende mange podnin-ger, f. eks. for 50 eller 100 personer.
Eksempel 1: 500 sukkerkjerner (Globuli sacchari,dia-meter 8 mm) blandes ved 20° C i en rote-rende kolbe, dråpevis med 20 ml av en blanding som inneholder en del av en vandig suspensjon av poliovirus type I (Sabin) med en ID50 107-835 og 2 deler av en sukker-oppløsning (2 deler sukker på 1 del vann), og tørkes ved hjelp av en steril luftstrøm ved 20° C og utstyres med et tarmoppløse-lig beskyttelsessjikt.
Titeren pr. sukkerkjerne utgjør etter fremstillingen 10s.6"7 IDfl(l = 665,000 etter 6 ukers lagring 105'375 ID5() = 237,000
De på denne måte fremstilte oralt an-vendbare preparater er holdbare i 6 uker ved værelsestemperatur under hensyntagen til prøvens feilgrense praktisk talt uten virkningstap.
Eksempel 2: På samme måte fremstilles ifølge oppfinnelsen poliomyelitvirus-preparater av poliovirus typeII (Sabin) med en ID50 1 07 ™.
Titeren utgjør pr. sukkerkjerne
etter fremstillingen IO5286 ID,n = 193,000 etter 6 ukers lagring 10"H IDm, = 225,000
Dette preparats aktivitet er praktisk talt uforandret etter 6 ukers lagring ved 20° C. Eksempel 3: Av poliovirus type III (Sabin) med en ID30 107 'H fremstilles tilsvarende fremgangsmåten ifølge eksempel 1 poliomyelit-preparater.
Titeren pr. sukkerkjerne utgjør etter fremstillingen IO3-685 ID.,n = 484,000 etter 6 ukers lagring 10S-417ID50 = 261,000
De målte titere viser at aktiviteten av de lagrede preparat bibeholdes innen prø-vens feilgrense.
Eksempel 4: 20 ml poliovirus type I (Sabin) med en ID-0 IO7'835, 20 ml poliovirus type II (Sabin) med en ID,-U 107 3,l,) og 20 ml poliovirus type III (Sabin) med en ID,n IO7 444 blandes med hverandre og forarbeides tilsvarende den i eksempel 1 angitte fremgangsmåte til poliovirus-preparater.
Titeren pr. sukkerkjerne for alle tre typer sammen : etter fremstillingen los806 ID-„ = 381,000 etter 6 ukers lagring 105'715ID-0 <=> 373,000
Som det kan sees av dataene er prepa-ratet som inneholder typene I, II og III lagringsdyktige i 6 uker uten aktivitetstap.
Claims (1)
- Fremgangsmåte til fremstilling av holdbare oralt administrerbare poliomyelit-virus-preparater av avsvekkede levende poliomyelitvira, karakterisert ved at man påfører poliomyelitvira på sukkerkjerner og tørker.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO75751349A NO145761C (no) | 1972-05-03 | 1975-04-16 | Benzodiazocinderivater for anvendelse som utgangsmaterialer ved fremstilling av benzodiazepinderivater, og en ny fremgangsmaate for fremstilling av disse benzodiazocinderivater |
NO76761580A NO143347C (no) | 1972-05-03 | 1976-05-07 | Utgangsmateriale for fremstilling av benzodiazepinderivater |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2221558A DE2221558C2 (de) | 1972-05-03 | 1972-05-03 | 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
NO142866B true NO142866B (no) | 1980-07-28 |
NO142866C NO142866C (no) | 1980-11-05 |
Family
ID=5843904
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO1797/73A NO142866C (no) | 1972-05-03 | 1973-05-02 | Nye benzodiazepinderivater for anvendelse som ugangsmateriale og fremgangsmaate ved fremstilling derav |
NO75751349A NO145761C (no) | 1972-05-03 | 1975-04-16 | Benzodiazocinderivater for anvendelse som utgangsmaterialer ved fremstilling av benzodiazepinderivater, og en ny fremgangsmaate for fremstilling av disse benzodiazocinderivater |
NO76761580A NO143347C (no) | 1972-05-03 | 1976-05-07 | Utgangsmateriale for fremstilling av benzodiazepinderivater |
NO780402A NO142476C (no) | 1972-05-03 | 1978-02-06 | Fremgangsmaate ved fremstilling av benzodiazepinderivater |
NO793012A NO144386C (no) | 1972-05-03 | 1979-09-19 | Fremgangsmaate ved fremstilling av benzodiazepinderivater |
NO793013A NO144885C (no) | 1972-05-03 | 1979-09-19 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO75751349A NO145761C (no) | 1972-05-03 | 1975-04-16 | Benzodiazocinderivater for anvendelse som utgangsmaterialer ved fremstilling av benzodiazepinderivater, og en ny fremgangsmaate for fremstilling av disse benzodiazocinderivater |
NO76761580A NO143347C (no) | 1972-05-03 | 1976-05-07 | Utgangsmateriale for fremstilling av benzodiazepinderivater |
NO780402A NO142476C (no) | 1972-05-03 | 1978-02-06 | Fremgangsmaate ved fremstilling av benzodiazepinderivater |
NO793012A NO144386C (no) | 1972-05-03 | 1979-09-19 | Fremgangsmaate ved fremstilling av benzodiazepinderivater |
NO793013A NO144885C (no) | 1972-05-03 | 1979-09-19 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater |
Country Status (18)
Country | Link |
---|---|
US (6) | US3998809A (no) |
JP (3) | JPS5541231B2 (no) |
AT (3) | AT327927B (no) |
BE (1) | BE799001A (no) |
CA (3) | CA1009232A (no) |
CH (5) | CH611608A5 (no) |
DD (1) | DD105222A5 (no) |
DE (3) | DE2265371C3 (no) |
DK (3) | DK147050C (no) |
ES (1) | ES414279A1 (no) |
FR (3) | FR2183735B1 (no) |
GB (3) | GB1429666A (no) |
IL (5) | IL48141A (no) |
NL (1) | NL179111C (no) |
NO (6) | NO142866C (no) |
SE (3) | SE409709B (no) |
SU (2) | SU526290A3 (no) |
ZA (1) | ZA733013B (no) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2265371C3 (de) * | 1972-05-03 | 1980-12-11 | Kali-Chemie Ag, 3000 Hannover | N-(3-Benzoylaminopropyl)-aniline |
US4244869A (en) * | 1972-05-03 | 1981-01-13 | Kali-Chemie A.G. | Benzodiazepine derivatives and process of making them |
DE2520937C3 (de) * | 1975-05-10 | 1978-10-12 | Kali-Chemie Ag, 3000 Hannover | 7-Brom-1 -methyl^-alkoxymethyl-S-(2-halogenphenyl)-lH-23-dihydro-l,4benzodiazepinderivate, deren Säureadditionssalze und pharmazeutische Präparate |
DE2720968C2 (de) * | 1977-05-10 | 1986-05-07 | Kali-Chemie Pharma Gmbh, 3000 Hannover | N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel |
DE2720908A1 (de) * | 1977-05-10 | 1978-11-23 | Kali Chemie Pharma Gmbh | Arzneimittel mit ulkustherapeutischem effekt |
ES469020A1 (es) * | 1977-05-10 | 1979-09-01 | Kali Chemie Pharma Gmbh | Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos |
US4123430A (en) * | 1977-11-10 | 1978-10-31 | G. D. Searle & Co. | 2-Aryl-4-(1-piperazinyl)-3H-1,5-benzodiazepines |
DE2754112A1 (de) * | 1977-12-05 | 1979-06-13 | Kali Chemie Pharma Gmbh | 1,4-benzodiazepinderivate, ihre salze und diese verbindungen enthaltende arzneipraeparate |
DE2810349A1 (de) * | 1978-03-10 | 1979-09-20 | Kali Chemie Pharma Gmbh | Verfahren zur herstellung von 3-hydroxy-6-phenyl-1,2,3,4-tetrahydro- 1,5-benzodiazocinen |
US4368157A (en) * | 1978-05-15 | 1983-01-11 | Hoffmann-La Roche Inc. | Intermediates to produce imidazodiazepines |
US4368158A (en) * | 1978-05-15 | 1983-01-11 | Hoffmann-La Roche Inc. | Intermediates to produce imidazodiazepines |
US4368159A (en) * | 1978-05-15 | 1983-01-11 | Hoffmann-La Roche Inc. | Intermediates to produce imidazodiazepines |
US4371468A (en) * | 1978-05-15 | 1983-02-01 | Hoffmann-La Roche Inc. | Intermediates to produce imidazodiazepines |
DE2827801A1 (de) * | 1978-06-24 | 1980-01-10 | Kali Chemie Pharma Gmbh | Neue n tief 1 -benzoyl-n tief 2 -phenyl-1,3-diaminopropan-2-ole, verfahren zu deren herstellung und arzneimittel |
DE2835708A1 (de) * | 1978-08-16 | 1980-03-06 | Kali Chemie Pharma Gmbh | Neue eckige klammer auf 1,2 eckige klammer zu-anellierte 7-phenyl-1,4-benzodiazepinderivate, verfahren zu deren herstellung und arzneimittel |
JPS5775313A (en) * | 1980-10-30 | 1982-05-11 | Fanuc Ltd | Numerical controller of machine tool |
DE3048264A1 (de) * | 1980-12-20 | 1982-09-09 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3124013A1 (de) * | 1981-06-19 | 1982-12-30 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 2-acylaminomethyl-1,4-benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3138769A1 (de) * | 1981-09-30 | 1983-04-14 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 7-brom-5-(2-halogenphenyl)-1h-2,3-dihydro-1,4- benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3151597A1 (de) * | 1981-12-28 | 1983-07-07 | Kali-Chemie Pharma Gmbh, 3000 Hannover | (1,2)-anellierte 1,4-benzodiazepin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3221402A1 (de) * | 1982-06-05 | 1983-12-08 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 5-phenyl-1,4-benzodiazepine enthaltende analgetisch wirksame pharmazeutische zubereitungen |
US4493168A (en) * | 1983-06-16 | 1985-01-15 | Coburn Optical Industries, Inc. | Calibration gauge for computer-controlled lens generator, or the like |
US4602886A (en) * | 1983-12-28 | 1986-07-29 | Smit Adrianus J | Multi-color marking implement |
US4786449A (en) * | 1983-12-28 | 1988-11-22 | Clowny Corporation | Method for manufacture of multi-color marking implements |
EP0170024A3 (en) * | 1984-06-26 | 1990-01-31 | Merck & Co. Inc. | Use of 2-acylaminomethyl-1,4-benzodiazepine derivatives for the production of pharmaceutical compositions and process for the preparation for pharmaceutical compositions |
US4684646A (en) * | 1984-06-26 | 1987-08-04 | Merck & Co., Inc. | 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists |
US4724237A (en) * | 1984-06-26 | 1988-02-09 | Merck & Co., Inc. | 2-substituted-aminomethyl-1,4-benzodiazepines |
JPS61114933A (ja) * | 1984-11-12 | 1986-06-02 | Tokyo Electric Co Ltd | 事務機の給紙装置 |
JPH0618794Y2 (ja) * | 1987-06-17 | 1994-05-18 | 株式会社スギノマシン | ウォータジェット加工機 |
JPH0418564Y2 (no) * | 1988-01-08 | 1992-04-24 | ||
US5856497A (en) * | 1995-12-11 | 1999-01-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Asymmetric synthesis of α-cycloalkylalkyl substituted methanamines |
US5670640A (en) * | 1996-02-02 | 1997-09-23 | Hoffmann-La Roche Inc. | Process for the manufacture of imidazodiazepine derivatives |
US5831089A (en) * | 1996-07-01 | 1998-11-03 | Pharmacia & Upjohn Company | Process to produce midazolam |
US6818607B1 (en) * | 1999-08-27 | 2004-11-16 | Procter & Gamble Company | Bleach boosting components, compositions and laundry methods |
US7109156B1 (en) | 1999-08-27 | 2006-09-19 | Procter & Gamble Company | Controlled availability of formulation components, compositions and laundry methods employing same |
US6825160B1 (en) | 1999-08-27 | 2004-11-30 | Procter & Gamble Company | Color safe laundry methods employing cationic formulation components |
WO2001016276A1 (en) | 1999-08-27 | 2001-03-08 | The Procter & Gamble Company | Stability enhancing formulation components, compositions and laundry methods employing same |
US6821935B1 (en) | 1999-08-27 | 2004-11-23 | Procter & Gamble Company | Color safe laundry methods employing zwitterionic formulation components |
MXPA02002129A (es) * | 1999-08-27 | 2002-09-18 | Procter & Gamble | Componentes de formulacion de accion rapida, composiciones y metodos para lavanderia que los emplean. |
US6903060B1 (en) | 1999-08-27 | 2005-06-07 | Procter & Gamble Company | Stable formulation components, compositions and laundry methods employing same |
JP2003510251A (ja) * | 1999-08-27 | 2003-03-18 | ザ、プロクター、エンド、ギャンブル、カンパニー | ブリーチ増強成分、組成物および洗濯方法 |
US7169744B2 (en) | 2002-06-06 | 2007-01-30 | Procter & Gamble Company | Organic catalyst with enhanced solubility |
US7557076B2 (en) * | 2002-06-06 | 2009-07-07 | The Procter & Gamble Company | Organic catalyst with enhanced enzyme compatibility |
US20050113246A1 (en) * | 2003-11-06 | 2005-05-26 | The Procter & Gamble Company | Process of producing an organic catalyst |
AR051659A1 (es) * | 2005-06-17 | 2007-01-31 | Procter & Gamble | Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2721215A (en) * | 1952-06-12 | 1955-10-18 | Hoffmann La Rache Inc | Diphenylacetyl diamines |
US2785200A (en) * | 1953-06-08 | 1957-03-12 | Abbott Lab | Dichlorobenzoyl-ethylenediamine |
US2721214A (en) * | 1953-06-09 | 1955-10-18 | Parke Davis & Co | Process for producing acylamido diols |
US3576868A (en) * | 1966-06-03 | 1971-04-27 | Hoffmann La Roche | Benzoyl amino ethyl aniline derivatives |
US3501460A (en) * | 1966-06-03 | 1970-03-17 | Hoffmann La Roche | Dehydration process for forming benzodiazepines |
US3577557A (en) * | 1966-12-09 | 1971-05-04 | Sandoz Ag | Benzo(1,5)diazocinones |
US3723414A (en) * | 1970-02-13 | 1973-03-27 | Schering Corp | 1-polyfluoroalkyl benzodiazepines |
DE2166116A1 (de) * | 1970-04-24 | 1973-02-15 | Teikoku Hormone Mfg Co Ltd | Verfahren zur herstellung von n-(dialkylaminoalkylen)-2-alkoxy(oder -alkenyloxy)4-amino-5-halogenbenzamiden |
DK137857B (da) * | 1970-09-03 | 1978-05-22 | Takeda Chemical Industries Ltd | Analogifremgangsmåde til fremstilling af 2-amino-1,5-benzodiazocinderivater eller farmaceutisk acceptable salte deraf. |
JPS4728284Y1 (no) * | 1970-09-14 | 1972-08-26 | ||
US4021224A (en) * | 1971-12-09 | 1977-05-03 | Stauffer Chemical Company | Herbicide compositions |
DE2265371C3 (de) * | 1972-05-03 | 1980-12-11 | Kali-Chemie Ag, 3000 Hannover | N-(3-Benzoylaminopropyl)-aniline |
US3975443A (en) * | 1972-06-06 | 1976-08-17 | Allen & Hanburys Limited | 1-(3,4-dichlorobenzamidomethyl)-cyclohexyldimethylamine |
GB1374366A (en) * | 1972-07-21 | 1974-11-20 | Science Union & Cie | Propanol derivatives and a process for their preparation |
US3957870A (en) * | 1973-07-19 | 1976-05-18 | Imperial Chemical Industries Limited | Organic compounds |
-
1972
- 1972-05-03 DE DE2265371A patent/DE2265371C3/de not_active Expired
- 1972-05-03 DE DE2221558A patent/DE2221558C2/de not_active Expired
- 1972-05-03 DE DE2265370A patent/DE2265370C2/de not_active Expired
-
1973
- 1973-04-16 DD DD170247A patent/DD105222A5/xx unknown
- 1973-04-19 NL NLAANVRAGE7305570,A patent/NL179111C/xx not_active IP Right Cessation
- 1973-04-25 GB GB2491075A patent/GB1429666A/en not_active Expired
- 1973-04-25 GB GB3581775A patent/GB1429667A/en not_active Expired
- 1973-04-25 GB GB1974173A patent/GB1429665A/en not_active Expired
- 1973-04-26 CH CH1605677A patent/CH611608A5/xx not_active IP Right Cessation
- 1973-04-26 CH CH1605777A patent/CH611609A5/xx not_active IP Right Cessation
- 1973-04-26 CH CH1605577A patent/CH611607A5/xx not_active IP Right Cessation
- 1973-04-26 CH CH598873A patent/CH605834A5/xx not_active IP Right Cessation
- 1973-04-30 CA CA169,889A patent/CA1009232A/en not_active Expired
- 1973-04-30 CA CA169,890A patent/CA984388A/en not_active Expired
- 1973-05-01 IL IL48141A patent/IL48141A/xx unknown
- 1973-05-01 JP JP4900373A patent/JPS5541231B2/ja not_active Expired
- 1973-05-01 US US05/355,986 patent/US3998809A/en not_active Expired - Lifetime
- 1973-05-01 IL IL42158A patent/IL42158A/xx unknown
- 1973-05-01 IL IL47693A patent/IL47693A/xx unknown
- 1973-05-02 FR FR7315752A patent/FR2183735B1/fr not_active Expired
- 1973-05-02 NO NO1797/73A patent/NO142866C/no unknown
- 1973-05-02 DK DK238573A patent/DK147050C/da not_active IP Right Cessation
- 1973-05-02 BE BE130663A patent/BE799001A/xx not_active IP Right Cessation
- 1973-05-02 SE SE7306128A patent/SE409709B/sv unknown
- 1973-05-02 ES ES414279A patent/ES414279A1/es not_active Expired
- 1973-05-03 ZA ZA733013A patent/ZA733013B/xx unknown
- 1973-05-03 AT AT143875*1A patent/AT327927B/de not_active IP Right Cessation
- 1973-05-03 SU SU1920527A patent/SU526290A3/ru active
- 1973-05-03 AT AT389973A patent/AT327920B/de not_active IP Right Cessation
- 1973-05-03 SU SU731918571A patent/SU625607A3/ru active
- 1973-05-03 AT AT389873A patent/AT327919B/de not_active IP Right Cessation
-
1974
- 1974-12-19 FR FR7442122A patent/FR2248278B1/fr not_active Expired
-
1975
- 1975-04-16 NO NO75751349A patent/NO145761C/no unknown
- 1975-07-11 IL IL47693A patent/IL47693A0/xx unknown
- 1975-09-19 IL IL48141A patent/IL48141A0/xx unknown
-
1976
- 1976-04-02 FR FR7609742A patent/FR2296616A1/fr active Granted
- 1976-05-07 NO NO76761580A patent/NO143347C/no unknown
- 1976-05-12 US US05/685,537 patent/US4096141A/en not_active Expired - Lifetime
- 1976-09-02 CA CA260,433A patent/CA1020570A/en not_active Expired
- 1976-09-23 US US05/725,989 patent/US4098786A/en not_active Expired - Lifetime
- 1976-10-04 US US05/729,142 patent/US4216167A/en not_active Expired - Lifetime
- 1976-12-29 SE SE7614680A patent/SE422460B/xx unknown
- 1976-12-29 SE SE7614681A patent/SE7614681L/xx not_active Application Discontinuation
-
1977
- 1977-05-20 DK DK222977A patent/DK144969C/da not_active IP Right Cessation
- 1977-05-20 DK DK223077A patent/DK223077A/da unknown
- 1977-12-09 JP JP52148666A patent/JPS589101B2/ja not_active Expired
- 1977-12-09 JP JP52148667A patent/JPS5813535B2/ja not_active Expired
-
1978
- 1978-01-01 CH CH1605877A patent/CH620423A5/de not_active IP Right Cessation
- 1978-01-23 US US05/871,741 patent/US4243585A/en not_active Expired - Lifetime
- 1978-02-06 NO NO780402A patent/NO142476C/no unknown
-
1979
- 1979-09-19 NO NO793012A patent/NO144386C/no unknown
- 1979-09-19 NO NO793013A patent/NO144885C/no unknown
-
1984
- 1984-04-24 US US06/602,279 patent/US4595531A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO142866B (no) | Nye benzodiazepinderivater for anvendelse som ugangsmateriale og fremgangsmaate ved fremstilling derav | |
Koch et al. | The molecular biology of poliovirus | |
RU2339400C2 (ru) | Стабилизированная вакцинная композиция для стимулирования иммунного ответа и способ ее получения | |
KR19990022710A (ko) | 건조, 발포 유리 매트릭스에 물질을 안정하게 삽입시키는 방법 및 그 방법에 의해 얻어지는 조성물 | |
US3755557A (en) | Spray vaccines | |
CH646054A5 (fr) | Compositions d'agents anti-microbiens a liberation maitrisee. | |
BRPI0915696B1 (pt) | Composição de vacina de rotavírus liofilizada e método de preparar a referida composição | |
US20190070117A1 (en) | Novel Method for Vacuum-Assisted Preservation of Biologics Including Vaccines | |
CN107281210A (zh) | 阿奇霉素在抗冠状病毒感染中的应用 | |
CN102145165A (zh) | 2型猪圆环病毒和其用途 | |
US3937812A (en) | Feline calicivirus vaccine and production thereof | |
CN108472357A (zh) | Vlp稳定的疫苗组合物 | |
KR20090095668A (ko) | 포르시토사이드 주사제와 그 제조 방법 | |
SU1237081A3 (ru) | Способ производства лиофилизированной вакцины против гепатита уток | |
CN101219136A (zh) | 一种预防和治疗艾滋病的口服胶囊剂及其制备方法 | |
IL41902A (en) | Immunogenic substance,its production,vaccine preparations containing it and their preparation | |
RU2212895C2 (ru) | Вакцина против ящура типа о и способ ее изготовления | |
RU2143921C1 (ru) | Вакцина против ящура типа а и способ ее изготовления | |
CN105530958A (zh) | 粘膜疫苗组合物 | |
US3143473A (en) | Stable, solid, oral live antipoliomyelitis vaccine compositions and process for preparing them | |
CN1321694C (zh) | 冻干剂型艾滋病重组痘病毒安卡拉株载体疫苗及其制备方法 | |
CN105362284A (zh) | 阿奇霉素和泰利霉素在抗埃博拉病毒感染中的应用 | |
CN113288943A (zh) | 一种中药组合物在制备治疗或预防冠状病毒感染的药物中的应用 | |
JP2021522183A (ja) | バクテリオファージ組成物 | |
PT1387693E (pt) | Vacina de micoplasma inactivado por saponina |